{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:05:00Z","timestamp":1793394300194,"version":"4.5.0"},"reference-count":186,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.mcna.2016.08.008","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T09:32:29Z","timestamp":1479807149000},"page":"139-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Obesity"],"prefix":"10.1016","volume":"101","author":[{"given":"Dinko","family":"Susic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Varagic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2016.08.008_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/oby.2000.79","article-title":"Body mass index and the prevalence of hypertension and dyslipidemia","volume":"8","author":"Brown","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.mcna.2016.08.008_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","article-title":"Incidence and precursors of hypertension in young adults: the Framingham Offspring Study","volume":"16","author":"Garrison","year":"1987","journal-title":"Prev Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1359\/jbmr.081109","article-title":"How does body fat influence bone mass in childhood? A mendelian randomization approach","volume":"24","author":"Timpson","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.mcna.2016.08.008_bib4","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00004872-199412000-00018","article-title":"Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey","volume":"12","author":"Jones","year":"1994","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.103.6.1175","article-title":"The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study","volume":"103","author":"Freedman","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.mcna.2016.08.008_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.113.3.475","article-title":"Overweight, ethnicity, and the prevalence of hypertension in school-aged children","volume":"113","author":"Sorof","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.mcna.2016.08.008_bib8","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/CIRCULATIONAHA.107.730366","article-title":"Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis","volume":"117","author":"Chen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0895-7061(99)00123-5","article-title":"The effect of weight loss intervention on antihypertensive medication requirements in the Hypertension Optimal Treatment (HOT) study","volume":"12","author":"Jones","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","article-title":"Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II","volume":"134","author":"Stevens","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.numecd.2008.06.001","article-title":"Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity","volume":"19","author":"Dall'Asta","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.mcna.2016.08.008_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.109.129031","article-title":"Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study","volume":"54","author":"De","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.ijo.0802944","article-title":"Change in body mass index and its impact on blood pressure: a prospective population study","volume":"29","author":"Droyvold","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.mcna.2016.08.008_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ajh.2009.49","article-title":"Predictors of progression from prehypertension to hypertension in Japanese men","volume":"22","author":"Tomiyama","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(01)06710-1","article-title":"Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study","volume":"358","author":"Vasan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2016.08.008_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.1981.00340010073016","article-title":"Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity","volume":"141","author":"Messerli","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/01.CIR.66.1.55","article-title":"Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output","volume":"66","author":"Messerli","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000406429","article-title":"Obesity and essential hypertension","volume":"30","author":"Messerli","year":"1982","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.mcna.2016.08.008_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0002-9343(83)91071-9","article-title":"Disparate cardiovascular effects of obesity and arterial hypertension","volume":"74","author":"Messerli","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib21","doi-asserted-by":"crossref","first-page":"III71","DOI":"10.1161\/01.HYP.5.5_Pt_2.III71","article-title":"The problem of obesity and hypertension","volume":"5","author":"Frohlich","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/1047-2797(91)90039-F","article-title":"Obesity and hypertension. Hemodynamic aspects","volume":"1","author":"Frohlich","year":"1991","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-98-3-315","article-title":"Cardiovascular changes after weight reduction in obesity hypertension","volume":"98","author":"Reisin","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(82)92234-6","article-title":"Cardiovascular effects of obesity and hypertension","volume":"1","author":"Messerli","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2016.08.008_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/000331979304400907","article-title":"Abnormal erythrocyte rheology in patients with morbid obesity","volume":"44","author":"Levy","year":"1993","journal-title":"Angiology"},{"key":"10.1016\/j.mcna.2016.08.008_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-99-6-757","article-title":"Dimorphic cardiac adaptation to obesity and arterial hypertension","volume":"99","author":"Messerli","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0300-595X(76)80026-6","article-title":"Obesity and cardiovascular diseases: the Framingham study","volume":"5","author":"Gordon","year":"1976","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7326\/0003-4819-67-1-48","article-title":"The relation of adiposity to blood pressure and development of hypertension. The Framingham study","volume":"67","author":"Kannel","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jama.1978.03290150053024","article-title":"Weight and blood pressure. Findings in hypertension screening of 1 million Americans","volume":"240","author":"Stamler","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.08.008_bib30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/bmj.312.7041.1249","article-title":"Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group","volume":"312","author":"Elliott","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2016.08.008_bib31","doi-asserted-by":"crossref","first-page":"626S","DOI":"10.1093\/ajcn\/65.2.626S","article-title":"The INTERSALT Study: background, methods, findings, and implications","volume":"65","author":"Stamler","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mcna.2016.08.008_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1542\/peds.2011-3870","article-title":"Sodium intake and blood pressure among US children and adolescents","volume":"130","author":"Yang","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.mcna.2016.08.008_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/HYPERTENSIONAHA.115.05948","article-title":"High salt intake: independent risk factor for obesity?","volume":"66","author":"Ma","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00004872-199001000-00011","article-title":"The relation of cell volume, cell sodium and the transmembrane sodium gradient to blood pressure","volume":"8","author":"Friedman","year":"1990","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004872-199001000-00010","article-title":"The relation of blood sodium concentration to blood pressure in the rat","volume":"8","author":"Friedman","year":"1990","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.HYP.31.5.1083","article-title":"Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells","volume":"31","author":"Gu","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib37","first-page":"447","article-title":"Salt inactivates endothelial nitric oxide synthase in endothelial cells","volume":"139","author":"Li","year":"2009","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.mcna.2016.08.008_bib38","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0707791104","article-title":"Plasma sodium stiffens vascular endothelium and reduces nitric oxide release","volume":"104","author":"Oberleithner","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.mcna.2016.08.008_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2013.11.078","article-title":"A\u00a0reduction of 3 g\/day from a usual 9 g\/day salt diet improves endothelial function and decreases endothelin-1 in a randomised cross_over study in normotensive overweight and obese subjects","volume":"233","author":"Dickinson","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mcna.2016.08.008_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0021-9681(82)90119-9","article-title":"Effects of weight reduction on arterial pressure","volume":"35","author":"Reisin","year":"1982","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.mcna.2016.08.008_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM198908313210905","article-title":"The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents","volume":"321","author":"Rocchini","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib42","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/S0895-7061(97)00075-7","article-title":"Mechanisms of abnormal renal sodium handling in obesity hypertension","volume":"10","author":"Hall","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2014.05.057","article-title":"The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study","volume":"64","author":"Chandra","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/HYPERTENSIONAHA.110.157370","article-title":"Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events","volume":"56","author":"Chughtai","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.111.175315","article-title":"Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study","volume":"58","author":"Foster","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2796.1997.89104000.x","article-title":"Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity","volume":"241","author":"Sugerman","year":"1997","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-042711-135929","article-title":"Hyperaldosteronism as a common cause of resistant hypertension","volume":"64","author":"Calhoun","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s001090000144","article-title":"The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension","volume":"79","author":"Engeli","year":"2001","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.mcna.2016.08.008_bib49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","article-title":"Association of adrenal steroids with hypertension and the metabolic syndrome in blacks","volume":"49","author":"Kidambi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib50","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.01-0457fje","article-title":"Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation","volume":"15","author":"Massiera","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.mcna.2016.08.008_bib51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1381\/0960892053923734","article-title":"Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis","volume":"15","author":"Ruano","year":"2005","journal-title":"Obes Surg"},{"key":"10.1016\/j.mcna.2016.08.008_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension","volume":"55","author":"de","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/HJH.0b013e32835b6c02","article-title":"Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial","volume":"31","author":"Dorresteijn","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib54","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/00004872-200309000-00027","article-title":"Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study","volume":"21","author":"Grassi","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.HYP.30.1.140","article-title":"Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients with Hypertension (TROPHY) study group","volume":"30","author":"Reisin","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib56","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.28.6.1047","article-title":"Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity","volume":"28","author":"Alonso-Galicia","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib57","doi-asserted-by":"crossref","first-page":"R181","DOI":"10.1152\/ajpregu.00507.2004","article-title":"AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity","volume":"289","author":"Boustany","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.HYP.0000105624.68174.00","article-title":"Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration","volume":"43","author":"de Paula","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib59","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ajh\/6.12.1009","article-title":"Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs","volume":"6","author":"Robles","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/hy0202.104398","article-title":"Chronic cardiovascular and renal actions of leptin: role of adrenergic activity","volume":"39","author":"Carlyle","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib61","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/01.CIR.96.10.3423","article-title":"Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects","volume":"96","author":"Vaz","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.111.00791","article-title":"Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men","volume":"62","author":"Asferg","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib63","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/IJNRD.S39739","article-title":"Obesity, hypertension, and chronic kidney disease","volume":"7","author":"Hall","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.mcna.2016.08.008_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semnephrol.2012.12.003","article-title":"Structural renal changes in obesity and diabetes","volume":"33","author":"Amann","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.mcna.2016.08.008_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.arrt.2003.10.007","article-title":"Is obesity a major cause of chronic kidney disease?","volume":"11","author":"Hall","year":"2004","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.mcna.2016.08.008_bib67","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.V1261211","article-title":"Functional and structural changes in the kidney in the early stages of obesity","volume":"12","author":"Henegar","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2016.08.008_bib68","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/ndt\/gfr574","article-title":"Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population","volume":"27","author":"Burton","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mcna.2016.08.008_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib70","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.HYP.25.5.994","article-title":"Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs","volume":"25","author":"Hall","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1463-1326.2000.00092.x","article-title":"Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension","volume":"2","author":"Montagnani","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib72","first-page":"91","article-title":"Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives","volume":"14","author":"Gudbjornsdottir","year":"1996","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib73","first-page":"1081","article-title":"Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis","volume":"61","author":"Landsberg","year":"1986","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib74","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/01.HYP.19.6.621","article-title":"Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans","volume":"19","author":"Anderson","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib75","first-page":"R1350","article-title":"Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity","volume":"267","author":"Muntzel","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib76","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/01.hjh.0000234120.71142.6c","article-title":"Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake","volume":"24","author":"Liu","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib77","doi-asserted-by":"crossref","first-page":"R1240","DOI":"10.1152\/ajpregu.00493.2007","article-title":"Hyperinsulinemic rats are normotensive but sensitized to angiotensin II","volume":"294","author":"Johansson","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib78","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0895-7061(00)01261-9","article-title":"Hyperinsulinemia superimposed on insulin resistance does not elevate blood pressure","volume":"14","author":"Verma","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib79","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM199610173351617","article-title":"Sympathetic-nerve activity before and after resection of an insulinoma","volume":"335","author":"Scherrer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00586561","article-title":"Control by insulin of sodium potassium and water excretion by the isolated dog kidney","volume":"323","author":"Nizet","year":"1971","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.mcna.2016.08.008_bib81","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO;2-V","article-title":"Hyperleptinaemia: the missing link in the, metabolic syndrome?","volume":"14","author":"de Court","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/HYPERTENSIONAHA.107.099424","article-title":"Adiponectin, cardiovascular function, and hypertension","volume":"51","author":"Wang","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1590\/S0100-879X2000000600001","article-title":"Role of sympathetic nervous system and neuropeptides in obesity hypertension","volume":"33","author":"Hall","year":"2000","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.mcna.2016.08.008_bib84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0167-0115(03)00116-2","article-title":"Neural regulation of blood pressure by leptin and the related peptides","volume":"114","author":"Matsumura","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.mcna.2016.08.008_bib85","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib86","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/diabetes.51.2.439","article-title":"The concept of selective leptin resistance: evidence from agouti yellow obese mice","volume":"51","author":"Correia","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2016.08.008_bib87","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/diabetes.54.7.2012","article-title":"Role of selective leptin resistance in diet-induced obesity hypertension","volume":"54","author":"Rahmouni","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2016.08.008_bib88","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","article-title":"Mechanisms of leptin action and leptin resistance","volume":"70","author":"Myers","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib89","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/00365510701210186","article-title":"Circulating ghrelin levels in obese women: a possible association with hypertension","volume":"67","author":"Oner-Iyidogan","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.mcna.2016.08.008_bib90","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3892\/mmr.2012.1154","article-title":"Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model","volume":"7","author":"Zhang","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.mcna.2016.08.008_bib91","first-page":"1202","article-title":"Ghrelin and obestatin levels in hypertensive obese patients","volume":"42","author":"Wang","year":"2014","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.mcna.2016.08.008_bib92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.0300-0664.2001.01456.x","article-title":"Weight loss increases circulating levels of ghrelin in human obesity","volume":"56","author":"Hansen","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mcna.2016.08.008_bib93","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1097\/00004872-199917121-00026","article-title":"Contrasting blood pressure effects of obesity in leptin-deficient ob\/ob mice and agouti yellow obese mice","volume":"17","author":"Mark","year":"1999","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib94","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","volume":"84","author":"Ozata","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib95","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11906-008-0082-2","article-title":"Leptin and mechanisms of endothelial dysfunction and cardiovascular disease","volume":"10","author":"Knudson","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.mcna.2016.08.008_bib96","doi-asserted-by":"crossref","first-page":"H1514","DOI":"10.1152\/ajpheart.00479.2008","article-title":"Leptin-induced endothelial dysfunction in obesity","volume":"295","author":"Korda","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib97","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib98","first-page":"390","article-title":"Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats","volume":"232","author":"Tanida","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.mcna.2016.08.008_bib99","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2006-1841","article-title":"Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus","volume":"92","author":"Kos","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib100","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1210\/endo.143.6.8853","article-title":"Inactivation of the GR in the nervous system affects energy accumulation","volume":"143","author":"Kellendonk","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.mcna.2016.08.008_bib101","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1440-1681.2001.03584.x","article-title":"Glucocorticoid-induced hypertension: from mouse to man","volume":"28","author":"Whitworth","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib102","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1210\/jc.2002-030017","article-title":"Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians","volume":"88","author":"Lindsay","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/JOE-07-0090","article-title":"Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone","volume":"194","author":"Michailidou","year":"2007","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.mcna.2016.08.008_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI17845","article-title":"Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice","volume":"112","author":"Masuzaki","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.mcna.2016.08.008_bib105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.mcna.2011.06.004","article-title":"Hypertension in obesity","volume":"95","author":"Kurukulasuriya","year":"2011","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.mcna.2016.08.008_bib106","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.HYP.35.6.1270","article-title":"Physiology and pathophysiology of the adipose tissue renin-angiotensin system","volume":"35","author":"Engeli","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/VHRM.S33760","article-title":"The influence of perivascular adipose tissue on vascular homeostasis","volume":"9","author":"Szasz","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.mcna.2016.08.008_bib108","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2007-1088","article-title":"Body mass index predicts aldosterone production in normotensive adults on a high-salt diet","volume":"92","author":"Bentley-Lewis","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib109","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jc.2009-2521","article-title":"Aldosterone production and insulin resistance in healthy adults","volume":"95","author":"Garg","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12224","article-title":"Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects","volume":"16","author":"Garg","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.mcna.2016.08.008_bib111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.HYP.0000171479.36880.17","article-title":"Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats","volume":"46","author":"Blanco-Rivero","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib112","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/ars.2005.7.1294","article-title":"Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences","volume":"7","author":"Sanz-Rosa","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mcna.2016.08.008_bib113","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/HJH.0b013e3283537347","article-title":"Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension","volume":"30","author":"Jordan","year":"2012","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib114","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/oby.20181","article-title":"Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment\u2013a position paper of The Obesity Society and The American Society of Hypertension","volume":"21","author":"Landsberg","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.mcna.2016.08.008_bib115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/HYPERTENSIONAHA.111.185876","article-title":"Angiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressure","volume":"59","author":"Shaltout","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib116","first-page":"R222","article-title":"Autonomic nervous system activity in weight gain and weight loss","volume":"269","author":"Arone","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib117","first-page":"R1418","article-title":"Heart rate variability as a measure of autonomic function during weight change in humans","volume":"261","author":"Hirsch","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib118","first-page":"H629","article-title":"Reduced parasympathetic control of heart rate in obese dogs","volume":"269","author":"Van Vliet","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib119","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.36.4.538","article-title":"Adrenergic and reflex abnormalities in obesity-related hypertension","volume":"36","author":"Grassi","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.HYP.25.4.560","article-title":"Sympathetic activation in obese normotensive subjects","volume":"25","author":"Grassi","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib121","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/01.CIR.89.6.2634","article-title":"Body fat and sympathetic nerve activity in healthy subjects","volume":"89","author":"Scherrer","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib122","doi-asserted-by":"crossref","first-page":"R803","DOI":"10.1152\/ajpregu.00707.2003","article-title":"Obesity and hypertension: two epidemics or one?","volume":"286","author":"Davy","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib123","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-199917080-00012","article-title":"Neural mechanisms in human obesity-related hypertension","volume":"17","author":"Rumantir","year":"1999","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib124","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.107.094649","article-title":"Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension","volume":"50","author":"Lambert","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/HYPERTENSIONAHA.110.155663","article-title":"Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults","volume":"56","author":"Lambert","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib126","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.25.4.774","article-title":"Fatty acids enhance vascular alpha-adrenergic sensitivity","volume":"25","author":"Stepniakowski","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib127","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.0000242642.42177.49","article-title":"Mechanisms of sympathetic activation in obesity-related hypertension","volume":"48","author":"Esler","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.HYP.0000251679.87348.05","article-title":"Autonomic contribution to blood pressure and metabolism in obesity","volume":"49","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2013.00161","article-title":"The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness","volume":"4","author":"Aroor","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.mcna.2016.08.008_bib130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.mcna.2016.08.008_bib131","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2010.12.017","article-title":"Aortic stiffness: current understanding and future directions","volume":"57","author":"Cavalcante","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib132","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/ATVBAHA.107.149641","article-title":"Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression","volume":"27","author":"Femia","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mcna.2016.08.008_bib133","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.HYP.34.2.201","article-title":"Arterial stiffness and the development of hypertension. The ARIC study","volume":"34","author":"Liao","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib134","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2009.11.038","article-title":"Vascular insulin resistance in prehypertensive rats: role of PI3-kinase\/Akt\/eNOS signaling","volume":"628","author":"Li","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mcna.2016.08.008_bib135","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib136","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.yjmcc.2008.10.014","article-title":"Endothelial dysfunction in adiponectin deficiency and its mechanisms involved","volume":"46","author":"Cao","year":"2009","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib137","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1172\/JCI29623","article-title":"Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in\u00a0vivo","volume":"117","author":"Ouedraogo","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.mcna.2016.08.008_bib138","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.1074\/jbc.M206083200","article-title":"Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis","volume":"277","author":"Matsuda","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.mcna.2016.08.008_bib139","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/oby.2006.196","article-title":"Impact of obesity in intima media thickness of carotid arteries","volume":"14","author":"Kotsis","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.mcna.2016.08.008_bib140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mcna.2016.08.008_bib141","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.38.3.399","article-title":"Blood pressure and inflammation in apparently healthy men","volume":"38","author":"Chae","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib142","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/HYPERTENSIONAHA.107.105668","article-title":"Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection","volume":"51","author":"Schnabel","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib143","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.atherosclerosis.2010.04.029","article-title":"Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases","volume":"212","author":"Faber","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mcna.2016.08.008_bib144","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.mcna.2016.08.008_bib145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/oby.2008.542","article-title":"Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery","volume":"17","author":"Gletsu-Miller","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.mcna.2016.08.008_bib146","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib147","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2337\/db06-0133","article-title":"Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity","volume":"55","author":"Cancello","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2016.08.008_bib148","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.mcna.2016.08.008_bib149","doi-asserted-by":"crossref","first-page":"529061","DOI":"10.4061\/2011\/529061","article-title":"Inflammatory concepts of obesity","volume":"2011","author":"Rocha","year":"2011","journal-title":"Int J Inflam"},{"key":"10.1016\/j.mcna.2016.08.008_bib150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mam.2011.10.011","article-title":"Immunity as a link between obesity and insulin resistance","volume":"33","author":"Kalupahana","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib151","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/HYPERTENSIONAHA.111.183178","article-title":"Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance","volume":"59","author":"Ohshima","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib152","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2337\/db13-1094","article-title":"T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance","volume":"63","author":"Zhong","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2016.08.008_bib153","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2016.08.008_bib154","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Eckel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib155","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2016.08.008_bib156","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.1992.03480090061028","article-title":"The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I","volume":"267","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.08.008_bib157","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jama.279.11.839","article-title":"Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group","volume":"279","author":"Whelton","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.08.008_bib158","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.0000202568.01167.B6","article-title":"Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association","volume":"47","author":"Appel","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib159","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.HYP.35.2.544","article-title":"Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension","volume":"35","author":"He","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJM199302253280804","article-title":"The association of changes in physical-activity level and other lifestyle characteristics with mortality among men","volume":"328","author":"Paffenbarger","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib161","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib162","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2016.08.008_bib163","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.08.008_bib164","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/eurheartj\/ehn076","article-title":"Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study","volume":"29","author":"Van Gaal","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2016.08.008_bib165","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.106.625400","article-title":"Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study","volume":"115","author":"Scholze","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.08.008_bib166","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"Poirier","year":"2006","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2016.08.008_bib167","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2013the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.mcna.2016.08.008_bib168","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.08.008_bib169","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-7061(98)00141-1","article-title":"Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?","volume":"11","author":"Jacob","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","article-title":"New-onset diabetes and antihypertensive drugs","volume":"24","author":"Mancia","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib171","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1467-789X.2001.00044.x","article-title":"Use of beta-blockers in obesity hypertension: potential role of weight gain","volume":"2","author":"Pischon","year":"2001","journal-title":"Obes Rev"},{"key":"10.1016\/j.mcna.2016.08.008_bib172","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.hjh.0000234121.48272.67","article-title":"Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients","volume":"24","author":"Kaiser","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib173","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2016.08.008_bib174","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2165\/00003495-200464220-00004","article-title":"Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system","volume":"64","author":"Scheen","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.mcna.2016.08.008_bib175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.HYP.37.1.12","article-title":"Baseline characteristics and early blood pressure control in the CONVINCE trial","volume":"37","author":"Black","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib176","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.mcna.2016.08.008_bib177","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A\u00a0calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.08.008_bib178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00045415-200205000-00001","article-title":"Clinical management of the obese hypertensive patient","volume":"10","author":"Frohlich","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.mcna.2016.08.008_bib179","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/jhh.2013.42","article-title":"A\u00a0critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension","volume":"28","author":"Byrd","year":"2014","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11906-010-0123-5","article-title":"Drug mechanisms to help in managing resistant hypertension in obesity","volume":"12","author":"Jansen","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.mcna.2016.08.008_bib181","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.106.084301","article-title":"Direct renin inhibition with aliskiren in obese patients with arterial hypertension","volume":"49","author":"Jordan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.008_bib182","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/HJH.0b013e32832be593","article-title":"Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial","volume":"27","author":"Schmieder","year":"2009","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.008_bib183","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1368-5031.2006.00951.x","article-title":"Selective imidazoline agonist moxonidine in obese hypertensive patients","volume":"60","author":"Sanjuliani","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.mcna.2016.08.008_bib184","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2016.08.008_bib185","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coph.2010.08.002","article-title":"Mechanisms of adiponectin regulation and use as a pharmacological target","volume":"10","author":"Phillips","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.mcna.2016.08.008_bib186","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.lfs.2009.11.020","article-title":"Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control","volume":"86","author":"Ferrario","year":"2010","journal-title":"Life Sci"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516373278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516373278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:22:37Z","timestamp":1657804957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712516373278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":186,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0025712516373278"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2016.08.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2016.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}